Uveal Diseases  >>  TheraSphere (yttrium 90 microspheres)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
TheraSphere (yttrium 90 microspheres) / Boston Scientific
NCT01730157: Radioembolization and Ipilimumab in Treating Patients With Uveal Melanoma With Liver Metastases

Terminated
1
6
US
ipilimumab, anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody, MDX-010, MDX-CTLA-4, monoclonal antibody CTLA-4, yttrium Y 90 glass microspheres, TheraSphere, laboratory biomarker analysis
Case Comprehensive Cancer Center, National Cancer Institute (NCI)
Ciliary Body and Choroid Melanoma, Medium/Large Size, Ciliary Body and Choroid Melanoma, Small Size, Extraocular Extension Melanoma, Iris Melanoma, Liver Metastases, Metastatic Intraocular Melanoma, Recurrent Intraocular Melanoma, Stage IV Intraocular Melanoma
02/16
02/16

Download Options